搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
腾讯网
4 分钟
“万物皆可毛绒”的喜与忧
原标题:“万物皆可毛绒”的喜与忧陕西的“绒馍馍”、甘肃的“麻辣烫”、江苏的吴王夫差胖宝剑、广东的“烧鹅”“乳鸽”……近期,多个地方和博物馆推出极具地域特色、文化特色的毛绒文创,在年轻群体中“圈粉”无数。这边厢文创雪糕、冰箱贴还在持续火爆,那边厢毛绒文创已经打开了新的思路和赛道。毛绒文创造型可爱、手感 ...
2 天
on MSN
Pay commitments could see end to dispute which saw PKC schools disruption
An end to the pay dispute, which saw a two-week strike by Perth and Kinross non-teaching staff, closing schools, could be in ...
11 小时
on MSN
Video shows person lurking behind Southbridge buildings before fire, neighbor says
Two buildings caught fire overnight in Southbridge, Massachusetts. The large fire broke out around 3:24 a.m. on Union Street.
1 天
4M Therapeutics Awarded $120,000 Grant from SynGAP Research Fund to Evaluate GSK3β ...
M Therapeutics Awarded $120,000 Grant from SynGAP Research Fund to Evaluate GSK3β Inhibition in Preclinical SYNGAP1-Related Disorders Research ...
5 天
Perth and Kinross Council now exploring options on how to tackle static caravan planning ...
After acknowledging it did not have planning approval, the local authority had closed the case in April and decided not to ...
6 天
on MSN
Hundreds of people sign petition opposing closure of Comrie Library
A campaign to save a closure-threatened Perthshire library has attracted more than 500 signatures opposing the move. Comrie ...
Le Lézard
1 天
4M Therapeutics Awarded $120,000 Grant from SynGAP Research Fund to Evaluate GSK3 ...
M Therapeutics Inc. (4MTx), an early-stage biotechnology company developing treatments for neuropsychiatric and neurodegenerative diseases, today announced that the Company has been awarded a $120,000 ...
Sailing
4 天
L'Occitane Sailing Team set for the Vendée Globe
Four years after completing her first solo circumnavigation of the globe, Clarisse Crémer is preparing to repeat the ...
6 天
Cassava Sciences: Pivotal Alzheimer's Data May Push Stock Toward Book Value
Cassava Sciences' RETHINK-ALZ trial is nearing data release. See why SAVA stock could see volatility depending on trial ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈